EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development

EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development

Source: 
Pharmaceutical Business Review
snippet: 


EpiVax is joining Intravacc and Coalition for Epidemic Preparedness Innovations (CEPI) on a new project to develop universal vaccines for betacoronaviruses, including SARS-CoV-2.